Dentons and Latham & Watkins advised ATAI Life Sciences on the deal, while Davis Polk advised the underwriters. Clinical-stage biopharmaceutical company ATAI Life Sciences launched its...
This content is for Standard 1 Year members only. LoginJoin Now